Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Arch Ophthalmol. 2009 Jan;127(1):22–30. doi: 10.1001/archophthalmol.2008.520
20/160 1%
20/125 2%* 1%* 1%*
20/100 8% 17% 2% 1% 2% 2% 1%
20/80 16% 17% 4% 4% 2% 2% 2% 5%
20/63 32% 31% 12% 11% 6% 8% 5% 7%
20/50 27% 19% 27% 15% 17% 7% 7% 8%
20/40 18% 17% 20% 24% 24% 19% 21% 10%
20/32 21% 33% 27% 31% 33% 27%
20/25 11% 11% 13% 21% 15% 22%
20/20 4% 9% 9% 13% 14%
20/16 1% 5%
Mean logMAR 0.47 0.50 0.32 0.31 0.26 0.24 0.23 0.22
(SD) 0.12 0.13 0.16 0.15 0.15 0.16 0.16 0.20
Mean Lines -- -- 1.5 1.9 2.1 2.6 2.4 2.8
Change
(SD) 1.3 1.3 1.2 1.5 1.4 1.8
Treatment Group A A + P A A + P A A + P A A + P
Visit Baseline 5 Weeks 10 Weeks 18 Weeks
*
Amblyopic eye visual acuity at 18 weeks was 1 line worse than at baseline, but then better than or equal to baseline upon retesting during the same visit; however, by protocol the first acuity test was counted as the “outcome” examination.
Amblyopic eye visual acuity decreased from 20/80 at baseline to 20/160 at 18 weeks for an unknown reason.